Reckitt Benckiser Group
RBGLY | OTC
$13.49
+$0.05 (+0.37%)
Sep 22, 2026, 1:35 PM ET · Market open
Fiscal Year Period Ending | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 | FY 2019 Dec 30, 2019 |
|---|---|---|---|---|---|---|
Revenue | 14.17B | 14.61B | 14.45B | 13.23B | 13.99B | 12.85B |
Cost of Revenue | 5.57B | 5.85B | 6.09B | 5.54B | 5.56B | 5.07B |
Gross Profit | 8.6B | 8.76B | 8.36B | 7.69B | 8.44B | 7.78B |
Operating Income | 2.43B | 2.53B | 3.25B | -804M | 2.16B | -1.71B |
Interest Income | 53M | 41M | 29M | 29M | 61M | 161M |
Pretax Income | 2.1B | 2.4B | 3.07B | -260M | 1.87B | -2.11B |
Net Income | 1.43B | 1.64B | 2.33B | -32M | 1.19B | -2.77B |
Selling & General & Admin | 4.83B | 5.09B | 4.64B | 4.65B | 5B | 4.16B |
Research & Development | 325M | 337M | 325M | 313M | 288M | 257M |
Other Expenses | 1.01B | 807M | 158M | 3.52B | 983M | 202M |
Operating Expenses | 6.17B | 6.23B | 5.13B | 8.48B | 6.28B | 4.62B |
Interest Expense | 393M | 309M | 233M | 244M | 276M | 314M |
Selling & Marketing Expenses | 3.54B | 3.7B | 3.44B | 3.46B | 3.61B | 3.42B |
Cost & Expenses | 11.74B | 12.08B | 11.22B | 14.04B | 11.83B | 9.68B |
Income Tax Expense | 672M | 753M | 711M | 208M | 720M | 665M |
Shares Outstanding (Basic) | 3.5B | 3.58B | 3.58B | 3.57B | 3.55B | 3.54B |
Shares Outstanding (Diluted) | 3.51B | 3.59B | 3.59B | 3.57B | 3.57B | 3.54B |
EPS (Basic) | 0.41 | 0.46 | 0.65 | -0.02 | 0.33 | -0.78 |
EPS (Diluted) | 0.41 | 0.46 | 0.65 | -0.02 | 0.33 | -0.78 |
EBITDA | 2.96B | 3.19B | 3.65B | 3.02B | 3.49B | -1.32B |
EBIT | 2.5B | 2.71B | 3.36B | 2.73B | 3.15B | -1.76B |
Depreciation & Amortization | 461M | 470M | 286M | 292M | 335M | 436M |
Add to Watchlist
Select watchlists to add or remove RBGLY